Document Detail


Malignant hyperthermia susceptibility in X-linked muscle dystrophies.
MedLine Citation:
PMID:  3508709     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To evaluate malignant hyperthermia (MH) susceptibility in X-linked muscular dystrophies, halothane and caffeine contracture tests were performed on muscle fiber bundles from five patients with Duchenne muscular dystrophy (DMD) and two patients with Becker muscular dystrophy (BMD). Two DMD patients and one BMD patient had positive contracture tests. Since a positive contracture test is currently the best indicator of anesthetic susceptibility in the MH population, and episodes of MH in dystrophic patients have been reported, patients with DMD and BMD may be at risk for developing similar anesthetic complications. Awareness of this potential anesthetic risk is of importance because orthopedic interventions are increasingly more common in these patients.
Authors:
T D Heiman-Patterson; H M Natter; H R Rosenberg; J E Fletcher; A J Tahmoush
Related Documents :
12705499 - A novel 6 bp insertion in exon 7 associated with an unusual phenotype in a family with ...
20123959 - Chronic mucocutaneous candidiasis in apeced or thymoma patients correlates with autoimm...
4037759 - Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectr...
20881489 - Biomarkers in frontotemporal lobar degeneration.
19754869 - Trichothiodystrophy and fragile hair: the distinction between diagnostic signs and diag...
17976519 - Numerical gain and structural rearrangements of jak2, identified by fish, characterize ...
1840819 - Clinical course and diagnosis of migraine headaches in hydrocephalic children.
16886149 - Comparison of epidemiological, clinical, and biological features of invasive aspergillo...
3122489 - Lack of correlation between plasma cell thymidine labelling index and serum beta-2-micr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pediatric neurology     Volume:  2     ISSN:  0887-8994     ISO Abbreviation:  Pediatr. Neurol.     Publication Date:    1986 Nov-Dec
Date Detail:
Created Date:  1989-06-23     Completed Date:  1989-06-23     Revised Date:  2006-05-23    
Medline Journal Info:
Nlm Unique ID:  8508183     Medline TA:  Pediatr Neurol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  356-8     Citation Subset:  IM    
Affiliation:
Department of Neurology, Hahnemann University Hospital, Philadelphia, PA 19102.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Caffeine / diagnostic use
Child
Halothane / diagnostic use
Humans
Linkage (Genetics)*
Muscle Contraction / drug effects
Muscular Dystrophies / genetics*
Sex Chromosome Aberrations / genetics*
X Chromosome*
Chemical
Reg. No./Substance:
151-67-7/Halothane; 58-08-2/Caffeine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Carbamazepine-exacerbated epilepsy in children and adolescents.
Next Document:  Travel vision: "collicular visual system"?